Scholar Rock Holding Corp (SRRK) - News Archive

Scholar Rock, a prominent Phase 3 clinical-stage biopharmaceutical company, recently announced the grant of employee inducement equity awards under the Nasdaq Listing Rule 5635(c)(4). This article will outline the facts...

In a recent financial report and corporate update, Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, showcased their significant progress in advancing treatment...

In a recent announcement, Scholar Rock, a clinical-stage biopharmaceutical company, revealed promising new data from its Phase 1 DRAGON trial of SRK-181. The study focuses on SRK-181 s potential as a selective inhibitor...

CAMBRIDGE, Mass. - Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on developing treatments for serious diseases involving protein growth factors, has announced that it will be hosting a...